U.S., Jan. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07313176) titled 'Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease' on Dec. 17, 2025.
Brief Summary: The primary objective of the study is to assess the effectiveness of LECIGON(R) treatment on the reduction in OFF time (h/day) from baseline at 12 months as measured by Movement Disorder Society-Unified Parkinson's Disease Rating Scale, Part IV (MDS-UPDRS IV).
Study Start Date: Jan., 2026
Study Type: OBSERVATIONAL
Condition:
Advanced Parkinson Disease
Intervention:
OTHER: No Intervention
This is a non-interventional study.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: B...